Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Transform Care

Identifying new methods to improve health and lower costs

The increased need for behavioral healthcare is putting pressure on a system that is ill-prepared to deal with an influx of patients.

Partner, Health and Life Sciences, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman

Some therapeutic sectors saw their compound annual growth rate drop 10% or more, deviating from long-term trends. Sales should return to normal growth trajectories as backlogs in procedures continue to clear out.

Partner, Health and Life Sciences, Oliver Wyman

The spike in virtual care over the past two years opens the door for healthcare organizations to improve the payment journey.

Principal, Financial Services, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

Climate change is a public health emergency. Healthcare organizations have a moral imperative to work together and create a healthier environment for their communities.

President and CEO, Providence

Merck executives share their strategy for embedding health equity across the pharma value chain.

Partner, Health and Life Sciences, Oliver Wyman
Principal, Oliver Wyman
Associate Vice President for Health Equity and Lead, Merck for Mothers
Former Executive Director of Health Equity, Merck

Insights in your inbox

Subscribe

New standards for data interoperability could redefine the value proposition for payers, providers, and patients.

Chief Strategy Officer, 1upHealth

Marsh McLennan Advantage

High-income countries have, on average, administered nearly 25 times more doses of coronavirus vaccines than low-income countries.

Winning back talent is becoming the fight of our lives.

Partner, Health and Life Sciences, Oliver Wyman
Partner and CMO, Health and Life Sciences, Oliver Wyman
Director, Marsh & McLennan Advantage, Healthcare

While women were more likely to consider seeking mental health support during the pandemic, men were more prone to getting care.

Partner, Health and Life Sciences, Organizational Effectiveness, Oliver Wyman
Senior Knowledge Expert, Oliver Wyman
Lead Data Scientist, Health and Life Sciences, Oliver Wyman

Roughly 17% of Americans may have unrecognized depression. Left undiagnosed, the condition can increase direct healthcare costs and negatively impact the patient’s overall health. There needs to be greater focus on early detection and access to care when needed.

Chief Medical Director, Happify Health

Insights in your inbox

Subscribe